News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • UnitedHealth beat Q3, Optum margins expanded to 5.6%, and company raised 2026 EPS guidance to at least $20.50.
  • Analyst recommends a long UNH trade: entry near $419.29, stop $385.00, target $480.00 on a 180-trading-day horizon.
  • Sanofi trades near its 52-week low while Dupixent growth accelerates and the stock yields about 4.5%.
  • Analyst calls SNY a buy-the-dip with entry $41.00, target $46.00, stop $38.50 over roughly 45 trading days.
  • Insurer margin recovery and pharma dividend appeal support risk-on flows into large-cap healthcare stocks.

Latest Articles

Buy Ethos Technologies: Undervalued Growth with Room to Re-rate

Buy Ethos Technologies: Undervalued Growth with Room to Re-rate

Ethos Technologies appears to be the cheapest meaningful growth story in its peer set. The business combines recurring software revenue, accelerating go-to-market traction, and improving unit economics. We lay out a clear trade plan for a long-term re-rating, with catalysts, risks, and a stop/target framework aligned to company-specific milestones.

Alphabet's AI Pivot: Positioning for a New Growth Cycle

Alphabet's AI Pivot: Positioning for a New Growth Cycle

Alphabet's AI-first moves—paired with a large balance sheet, strong profitability and an attractively modest P/E—create a tangible re-rating opportunity. We lay out a long trade with entry, stop and target that balances upside from Gemini and Cloud monetization against near-term execution, legal and capex risks.

LGI Homes, Inc. Reports August 2026 Home Closings

LGI Homes, Inc. Reports August 2026 Home Closings

LGI Homes, Inc. announced it closed 409 homes in August 2026, representing a 9.9% increase compared to August 2025. The company currently has 153 active selling communities and continues its growth trajectory with a strong focus on quality construction and customer service across 36 markets in 21 states.

Terrestrial Energy: A Long Volatility Play on the AI Power Crunch

Terrestrial Energy: A Long Volatility Play on the AI Power Crunch

Terrestrial Energy positions itself as an industrial-scale supplier of firm, low-carbon power to data centers and AI infrastructure. We lay out a tactical long trade: entry at $3.25, stop at $2.10, target $6.50 over a long-term (180 trading days) horizon, sized for high-risk, high-reward exposure tied to licensing and offtake catalysts.

Oil Climbs as US-Iran Clashes and Shipping Restrictions Raise Supply Concerns

Oil Climbs as US-Iran Clashes and Shipping Restrictions Raise Supply Concerns

Oil prices rose on Friday and are set for the biggest weekly advance since mid-July as heightened U.S.-Iran tensions and new Iranian rules for vessels transiting the Strait of Hormuz intensified worries over Middle East supply disruptions. Brent traded near $95.67 per barrel and U.S. crude around $91.56, with substantial weekly percentage gains.

DSS, Inc. Announces Launch of Proposed Public Offering

DSS, Inc. Announces Launch of Proposed Public Offering

DSS, Inc., a diversified multinational company listed on the NYSE American under ticker DSS, has launched a proposed public offering of its common stock to raise capital for general corporate and working capital purposes. The offering is subject to market conditions, with Aegis Capital Corp. acting as the sole book-running manager. DSS operates in …

Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

Stoke Therapeutics and Biogen presented long-term clinical data at the 16th European Epilepsy Congress showing that zorevunersen, an investigational antisense oligonucleotide, produced substantial and durable reductions in seizures including severe seizure types that increase risk of SUDEP, alongside improvements in cognition, behavior, and quality…

Buy Paychex into WISE AI Momentum — Swing for a Dividend-Backed Upside

Buy Paychex into WISE AI Momentum — Swing for a Dividend-Backed Upside

Paychex's agentic WISE AI is moving from pilot to scale: 50,000 customers, 350,000 workforce conversations and nearly 90% of payroll errors flagged before runs. At a $44.5B market cap, the company still generates $2.28B in free cash flow and yields ~3.6% — a combination that supports a measured long trade. This idea outlines an entry at $125.08, st…

Toyota Weighs Hydrogen-Powered Trucks for Parts Logistics as Fuel Costs Rise

Toyota Weighs Hydrogen-Powered Trucks for Parts Logistics as Fuel Costs Rise

Toyota Motor Corp. is evaluating hydrogen as a fuel source for trucks that transport auto parts and as an energy option for factory operations, according to comments from Vice Chairman Koji Sato in an interview. The move reflects renewed interest in hydrogen as an alternative fuel amid higher gasoline prices and supply strains following the Iran wa…

XTEND Reality Expansion Ltd. and JFB Construction Holdings Complete Business Combination, Raising $110 Million in Total Capital

XTEND Reality Expansion Ltd. and JFB Construction Holdings Complete Business Combination, Raising $110 Million in Total Capital

XTEND AI Robotics, formed by the business combination of XTEND Reality Expansion Ltd. and JFB Construction Holdings, has successfully completed its merger and raised $110 million in total capital. The new combined company will trade on the NYSE starting September 4, 2026, under the ticker symbol XTND. With strengthened capital and a strategic focus…